DREAM3R: Durvalumab with chemotherapy as firstline treatment in advanced pleural mesothelioma - A phase 3 randomized trial Meeting Abstract
| Authors: | Forde, P. M.; Nowak, A. K.; Kok, P. S.; Brown, C.; Sun, Z.; Anagnostou, V.; O'Byrne, K. J.; Yip, S.; Cook, A.; Lesterhuis, W. J.; Hughes, B. G. M.; Pavlakis, N.; Brahmer, J. R.; Kindler, H. L.; Tsao, A. S.; Zauderer, M. G.; Ramalingam, S. S.; StocklerJohns, M. R. |
| Abstract Title: | DREAM3R: Durvalumab with chemotherapy as firstline treatment in advanced pleural mesothelioma - A phase 3 randomized trial |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120307034 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.TPS8586 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS8586 -- Source: Wos |
